Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2016-02-19 | Observable Networks | Convertible Note | $1.63M | DH Capital |
2015-09-22 | Veran Medical Technologies | Series E | $30.6M | 3G Capital Management, Advantage Capital, Dynamic Investments, Prolog Ventures, Rex Health Ventures, River Cities Capital Fund, and Versant Ventures |
2014-05-29 | Observable Networks | Series A - II | $2.45M | |
2014-05-16 | Proteon Therapeutics | Series D | $45M | Abingworth, Bessemer Venture Partners, Deerfield Management, Devon Park Bioventures, InterSouth Partners, MPM Capital, Pharmstandard International, Prism VentureWorks, Skyline Ventures, and TVM Capital Life Science |
2010-07-05 | EndoStim | Series B | $6M | Prolog Ventures, and Sante |